GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Cartesian Therapeutics, Inc. - Common Stock (RNAC)

Symbol: RNAC on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$1,842,696	255,539	+13,710	+5.7%	$7.21	Q4 2025
30 Sep 2025	0%	+0%	$2,471,880	241,829	+22,902	+10%	$10.22	Q3 2025
30 Jun 2025	0%	-0%	$2,275,016	218,927	-6,573	-2.9%	$10.39	Q2 2025
31 Mar 2025	0%	+0%	$2,972,650	225,500	+4,243		$13.18	Q1 2025
31 Dec 2024	0%	+0%	$3,963,088	221,257	+85,557	+63%	$17.91	Q4 2024
30 Sep 2024	0%	+0%	$2,187,625	135,700	+2,737	+2.1%	$16.12	Q3 2024
30 Jun 2024	0%	+0%	$3,591,578	132,963	+132,963	NEW	$27.01	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.